| European Case Law Identifier: | ECLI:EP:BA:2000:T120897.20001103 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 03 November 2000 | ||||||||
| Case number: | T 1208/97 | ||||||||
| Application number: | 88904041.6 | ||||||||
| IPC class: | C12P 21/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | SUBTILISIN ANALOGS | ||||||||
| Applicant name: | Amgen Inc. | ||||||||
| Opponent name: | (01) Novo Nordisk A/S (02) Unilever N.V. |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Appeal of Opponent 01 - inadmissible Main request - novelty (no) Auxiliary request - novelty (yes) - disclaimer Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t971208eu1.html
Date retrieved: 17 May 2021
